In vivo CAR T cell generation to treat cancer and autoimmune disease
Theresa Hunter(Unknown), Haig Aghajanian(Therapeutics Clinical Research), Diana Galvan, Stanley Zhang, Carl H. June(University of Pennsylvania), J. Robie Vestal, Romina Riener, Michael Rosenzweig(Boston University), Laura K. Shawver, Andrew L. Mammen(Malaysian Society of Nephrology), Josephine T. Nguyen, Annabel Wang, Ramin Farzaneh‐Far, Emiliano Pica, Ferran Soldevila, Goutam Mondal, Adrian Bot(Unknown), Daiki Matsuda, Michelle Nguyen(Arcturus Therapeutics (United States)), Jerel Vega, Aric M. Frantz, Brittany Ross, Gregor B. Adams, Steven P. Tanis, Scott Roberts, John Scholler(University of Pennsylvania), Junyi Li, Yan Zhang(Shandong University of Technology), J.H. Chen, Stuart A. Sievers, Matthew Butcher, D. Nguyen, Yi Chun Kuo, Yanjie Bao, Carolina Herrera, Donald Jhung, Priya Karmali(Arcturus Therapeutics (United States))
Cited by 219
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
|JCI Insight|2018|573
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
|Cancer Immunology Research|2015|332